Avicanna is a biotech company with a twist. The difference with Avicanna from your typical biotech startup is that Avicanna has several products already being sold on the market with proven efficacy. Avicanna is building a brand and validating its products through science. Their focus is on cannabis and creating products for various use cases. Aras Azadian, the CEO, and the management team are passionate about their work, and the insiders own a large portion of the companies shares. Avicanna will likely need to do an equity raise at some point, but management refuses to do one while the stock sits at depressed levels. Aras is extremely smart with a background in the Biotech arena. Avicanna has partnered with J&J, which validates the credibility of the company's initiative and the experience of this team. Once they get the financing completed, Avicanna should get to cash flow positive, which would be unique for a small biotech company. There is also potential for partnerships in the future and possibly being acquired. I think the Aras would consider any offers, but I also believe that unless the offer is too tough to pass up. Aras will wait until his team has a more established brand and proven product offering. Avicanna is a company to put on your radar. Watch the video, and you decide if this could be a long-term "Hidden Gem."
Produced with CyberLink PowerDirector 20
Produced with CyberLink PowerDirector 20
